3Q22 FDA Novel Drug Approvals

Prodigy tracks new-to-market drugs approved by the U.S. Food and Drug Administration (FDA). While the pipeline report includes all novel drugs that may or may not be currently indicated for conditions covered under workers’ compensation, it provides claims professionals with background information that could be useful if/when these products are prescribed for indicated conditions or off-label use.